Product Information
METFORMIN HCL 500 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.0140 per EA under NDC 71093013206. Its NADAC has been published 418 times since May 23, 2018.
FDA first approved this application on Sep 11, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093013206
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203769FDA Approved
9/11/2013
TE Code
AB
On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 500 MG TABLET has been published 418 times since May 23, 2018, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0140 per EA |
|---|---|
| All-time high | $0.0177 (Nov 16, 2022) |
| All-time low | $0.0123 (Nov 20, 2024) |
| 52-week high | $0.0147 |
| 52-week low | $0.0139 |
| Median price | $0.0156 |
| Average price | $0.0154 |
| Largest weekly change | +20.4% (Jun 19, 2024) |
| Weeks tracked | 418 |
| Tracking since | May 23, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.1%
1Y
-3.0%
3Y
-13.1%
5Y
-12.2%
All
-8.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.0140 per EA (NDC 71093013206), effective May 20, 2026.
How has the price of METFORMIN HCL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has declined 8.0%. It has been tracked across 418 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?
Since May 23, 2018, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0123 (Nov 20, 2024) to a high of $0.0177 (Nov 16, 2022), with a median of $0.0156 per EA.
Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL 500 MG TABLET?
METFORMIN HCL 500 MG TABLET (NDC 71093013206) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.